Sign in
4

Changes in Ownership

UNITED THERAPEUTICS Corp Filed Acc 0001106578-26-000137

Chairperson & CEO sold 9,500 shares at an average $499.03 ($4,740,795)

  • Chairperson & CEO acquired 9,500 shares (option exercise)
  • Traded under a Rule 10b5-1 plan

From the SEC's structured data for this filing

Trades in this filing

ROTHBLATT MARTINE A · Chairperson & CEO

Table I: Non-derivative

16 lines
Date Transaction Shares Price Value Owned after D/I
2026-09-08 Exercise or conversion : show line 1 in the form 10b5-1 +9,500 $117.76 $1,118,720 333,943 I
2026-09-08 Sale : show line 2 in the form 10b5-1 −40 $481.91 $19,276 333,903 I
2026-09-08 Sale : show line 3 in the form 10b5-1 −200 $483.90 $96,780 333,703 I
2026-09-08 Sale : show line 4 in the form 10b5-1 −220 $491.04 $108,028 333,483 I
2026-09-08 Sale : show line 5 in the form 10b5-1 −140 $492.72 $68,980 333,343 I
2026-09-08 Sale : show line 6 in the form 10b5-1 −144 $493.98 $71,133 333,199 I
2026-09-08 Sale : show line 7 in the form 10b5-1 −600 $494.87 $296,923 332,599 I
2026-09-08 Sale : show line 8 in the form 10b5-1 −256 $495.75 $126,912 332,343 I
Open-market sales · 9,500 sh · avg $499.03 · $4,740,795

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2026-09-08 Exercise or conversion : show line 17 in the form 10b5-1 Stock Option −9,500 480,410 I
Loading xslF345X06/primarydocument.xml…